- Report
- January 2024
- 167 Pages
Global
From €2414EUR$2,500USD£2,044GBP
- Report
- January 2024
- 274 Pages
Global
€4823EUR$4,995USD£4,084GBP
- Report
- January 2024
- 120 Pages
Global
€4823EUR$4,995USD£4,084GBP
- Report
- January 2024
- 243 Pages
Global
€4823EUR$4,995USD£4,084GBP
- Report
- July 2023
- 200 Pages
Global
From €4345EUR$4,500USD£3,679GBP
- Report
- July 2023
- 218 Pages
Global
From €4345EUR$4,500USD£3,679GBP
- Report
- October 2023
- 85 Pages
United States
From €4586EUR$4,750USD£3,883GBP
- Report
- March 2018
- 182 Pages
Global
From €1328EUR$1,375USD£1,124GBP
€2655EUR$2,750USD£2,248GBP
- Report
- July 2022
- 150 Pages
Global
From €5745EUR$5,950USD£4,865GBP
- Report
- August 2018
- 100 Pages
Global
From €5745EUR$5,950USD£4,865GBP
- Report
- July 2018
- 77 Pages
Global
From €5745EUR$5,950USD£4,865GBP
- Report
- February 2023
- 175 Pages
Global
From €4828EUR$5,000USD£4,088GBP
- Report
- March 2022
- 80 Pages
Global
From €917EUR$950USD£777GBP
- Report
- October 2022
- 270 Pages
Global
From €2897EUR$3,000USD£2,453GBP
€3621EUR$3,750USD£3,066GBP
- Report
- April 2022
- 326 Pages
Global
From €2897EUR$3,000USD£2,453GBP
€3621EUR$3,750USD£3,066GBP
- Report
- August 2020
- 112 Pages
Global
From €4103EUR$4,250USD£3,475GBP
- Report
- June 2020
- 114 Pages
Global
From €4586EUR$4,750USD£3,883GBP
- Report
- April 2023
- 180 Pages
Global
From €2897EUR$3,000USD£2,453GBP
- Report
- September 2022
- 141 Pages
Global
From €4586EUR$4,750USD£3,883GBP
- Report
- September 2022
- 282 Pages
Global
From €9172EUR$9,500USD£7,767GBP
![Loading Indicator](//www.researchandmarkets.com/images/loading.gif)
The Immune Disorders Drugs market is composed of drugs used to treat a variety of conditions related to the immune system. These drugs are used to treat autoimmune diseases, allergies, and other conditions that affect the body's ability to fight off infection. Inflammation drugs are a subset of these drugs, used to reduce inflammation and swelling caused by an immune response. These drugs can be used to treat a variety of conditions, including rheumatoid arthritis, psoriasis, and Crohn's disease. They can also be used to reduce the risk of infection in patients with weakened immune systems.
Inflammation drugs are typically administered orally or intravenously, and can be taken as a single dose or as part of a longer-term treatment plan. Common side effects of these drugs include nausea, vomiting, and diarrhea.
Companies in the Immune Disorders Drugs market include AbbVie, Amgen, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Merck, Novartis, Pfizer, and Roche. Show Less Read more